Related Experiment Video
Updated: Mar 24, 2026

07:11
Assessing Early Stage Open-Angle Glaucoma in Patients by Isolated-Check Visual Evoked Potential
Published on: May 25, 2020
6.9K
Glaucoma detection with damato multifixation campimetry online.
A S Olsen1,2, M Alberti1, L Serup3
1Department of Ophthalmology, Rigshospitalet, Copenhagen University Hospital, Glostrup, Denmark.
Eye (London, England)
|March 19, 2016
Summary
The Damato Multifixation Campimetry Online (DMCO) test shows potential for detecting glaucoma visual field loss, with high specificity and varying sensitivity based on disease severity. This free online tool is promising for identifying glaucomatous defects.
Area of Science:
- Ophthalmology
- Medical Technology
Background:
- Glaucomatous visual field loss requires accurate and accessible detection methods.
- Internet-based visual field testing offers a potential solution for widespread screening.
Purpose of the Study:
- To evaluate the Damato Multifixation Campimetry Online (DMCO) test's diagnostic performance for glaucoma.
- To assess the sensitivity and specificity of DMCO versions in detecting glaucomatous visual field loss.
- To develop and validate algorithms for interpreting DMCO results.
Main Methods:
- Diagnostic test evaluation involving 97 individuals comparing DMCO with standard white-on-white perimetry.
- Development and evaluation of interpretation algorithms using the Glaucoma Staging System as a gold standard.
- Calculation of Receiver Operating Characteristic (ROC) curves and Area Under the Curve (AUC) for algorithm performance.
Main Results:
- Algorithms achieved AUCs ranging from 0.79 to 0.90, with a promising algorithm combining two DMCO STANDARD tests.
- Sensitivity varied with glaucoma severity: 11.8% (mild), 71.4% (moderate), 100% (advanced), and 100% (severe).
- Specificity was high at 98.1%, with a median test duration of 86 seconds (controls) and 125 seconds (glaucoma patients) for DMCO STANDARD.
Conclusions:
- DMCO demonstrates potential as a free, online tool for identifying glaucomatous visual field defects in preselected populations.
- Further studies are investigating DMCO's utility in unselected populations.
- The test's accuracy is influenced by glaucoma severity, highlighting the need for careful interpretation.
Related Concept Videos
Glaucoma: Overview
1.6K
Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...
1.6K
Open Angle Glaucoma: Treatment
1.1K
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Drugs such as carbonic anhydrase inhibitors, α2- and...
1.1K
Angle Closure Glaucoma: Treatment
1.6K
Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
1.6K

